A Study to Evaluate the Metabolism and Excretion of BMS-986369 in Healthy Male Participants

Clinical trial NCT05567510 · COMPLETED

Trial details

NCT number: NCT05567510
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2022-10-20
Primary completion: 2022-12-27
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.